REV 5901, with the CAS number 101910-24-1, is a synthetic compound that has garnered interest in the field of medicinal chemistry, particularly for its potential applications in treating various diseases. It is characterized as a selective modulator of the retinoic acid receptor-related orphan receptor gamma (RORγt), which plays a crucial role in the regulation of immune responses and inflammation. The compound is typically studied for its ability to influence T-helper cell differentiation, particularly in the context of autoimmune diseases and inflammatory conditions. REV 5901 exhibits a unique chemical structure that allows it to interact specifically with RORγt, promoting or inhibiting certain biological pathways. Its pharmacological profile suggests potential therapeutic benefits, although further research is necessary to fully understand its efficacy, safety, and mechanism of action in clinical settings. As with many investigational compounds, detailed studies are ongoing to explore its full range of biological activities and potential applications in medicine.

REV 5901

101910-24-1: REV 5901, with the CAS number 101910-24-1, is a synthetic compound that has garnered interest in the field of medicinal chemistry, particularly for its potential applications in treating various diseases. It is characterized as a selective modulator of the retinoic acid receptor-related orphan receptor gamma (RORγt), which plays a crucial role in the regulation of immune responses and inflammation. The compound is typically studied for its ability to influence T-helper cell differentiation, particularly in the context of autoimmune diseases and inflammatory conditions. REV 5901 exhibits a unique chemical structure that allows it to interact specifically with RORγt, promoting or inhibiting certain biological pathways. Its pharmacological profile suggests potential therapeutic benefits, although further research is necessary to fully understand its efficacy, safety, and mechanism of action in clinical settings. As with many investigational compounds, detailed studies are ongoing to explore its full range of biological activities and potential applications in medicine.

<p>REV 5901: oral leukotriene receptor antagonist and 5-lipoxygenase inhibitor with Ki of 0.7 μM, researched for asthma.</p>

CAS 101910-24-1

REV 5901

REV 5901

Ref: IN-DA0005X0

REV 5901

Ref: 7W-GK9192

REV 5901

Ref: TM-T21821